| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5646660 | Journal of Allergy and Clinical Immunology | 2016 | 45 Pages |
Abstract
QGE031 has greater efficacy than omalizumab on inhaled and skin allergen responses in patients with mild allergic asthma. These data support the clinical development of QGE031 as a treatment of asthma.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Gail M. PhD, Jonathan P. MD, Louis-Philippe MD, Richard MBChB, Donald W. MD, Beth E. PhD, Irvin MD, J. Mark MB, Barbro MD, Kieran J. MB, Michel MD, Christopher MD, Nikolaos MD, Richard M. BSc, Joanne BSc, Veronica PhD, Miranda MSc, Linda MSc, Paul M. MB,